Study of worsening community pneumonia in people with weaker immunity
Part of Infections, Lungs & breathing clinical trials.
This study follows how community-acquired pneumonia progresses in hospitalized patients who already have serious health problems or weakened immune systems. The goal is to better understand risk and changes over time, which may help guide future care for people like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently hospitalized with community-acquired pneumonia (CAP) confirmed on a chest X-ray or CT scan
- A doctor believes the main reason for admission is pneumonia, and you can provide consent
- You have not been hospitalized in the past 28 days for any reason
- You have at least 2 pneumonia symptoms such as fever, cough, thick/yellow mucus, trouble breathing, or abnormal lung exam findings
- You have at least one major risk factor such as HIV/AIDS, recent cancer treatment, long-term steroids, or other serious conditions (like dialysis-dependent kidney disease or advanced heart or liver disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a retrospective study (looking back at past patient records) of people hospitalized with pneumonia to understand how the disease progresses and what factors affect recovery. Researchers will examine medical records of pneumonia patients admitted within 72 hours of symptom onset to identify patterns in who recovers well and who develops serious complications.
This study looks at patients with severe pneumonia caught outside the hospital. Researchers will review medical records to learn more about how this serious infection progresses.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
This study observes patients with pneumonia to better understand which patients become very sick and what happens to them over time. Researchers will collect information about your symptoms, test results, and how you recover to help doctors predict outcomes and improve care.
This trial tests a new medicine (OPT101) for people hospitalized with pneumonia and sepsis—where a lung infection causes body-wide inflammation and low oxygen. It aims to help patients who need extra oxygen but are not yet on a breathing machine.
This trial studies a new testing method (HCAP-Pcr) for people with pneumonia caught in the hospital or other healthcare settings. Doctors will use a special lung washing procedure called bronchoalveolar lavage to quickly identify the cause of the infection, which could help guide treatment faster.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.